Abstract
Oculogyric crisis (OGC) is an acute dystonia which can occur after initiation of antipsychotic treatment. Stereotypic paroxysmal psychiatric symptoms have been described along with OGC that resolve spontaneously when the later remits. We report a case of tardive OGC associated with zuclopenthixol in which there were associated paroxysmal auditory pseudohallucinations.
Keywords: Oculogyric crisis, dystonia, tardive, stereotypic paroxysmal psychiatric symptoms, pseudohallucinations, zuclopenthixol, antipsychotics, ocular pain, agitation, malaise, restlessness, anxiety, schizoid, cognitive, dopaminergic, cholinergic, GABA-ergic, neurobiology, FSC
Current Drug Safety
Title: Stereotyped Paroxysmal Psychiatric Symptoms During Oculogyric Crisis or ‘Cognitive Dystonia’: A Case Report
Volume: 6 Issue: 1
Author(s): Samir Kumar Praharaj, Sujit Sarkhel and Sayeed Akhtar
Affiliation:
Keywords: Oculogyric crisis, dystonia, tardive, stereotypic paroxysmal psychiatric symptoms, pseudohallucinations, zuclopenthixol, antipsychotics, ocular pain, agitation, malaise, restlessness, anxiety, schizoid, cognitive, dopaminergic, cholinergic, GABA-ergic, neurobiology, FSC
Abstract: Oculogyric crisis (OGC) is an acute dystonia which can occur after initiation of antipsychotic treatment. Stereotypic paroxysmal psychiatric symptoms have been described along with OGC that resolve spontaneously when the later remits. We report a case of tardive OGC associated with zuclopenthixol in which there were associated paroxysmal auditory pseudohallucinations.
Export Options
About this article
Cite this article as:
Kumar Praharaj Samir, Sarkhel Sujit and Akhtar Sayeed, Stereotyped Paroxysmal Psychiatric Symptoms During Oculogyric Crisis or ‘Cognitive Dystonia’: A Case Report, Current Drug Safety 2011; 6 (1) . https://dx.doi.org/10.2174/157488611794479982
DOI https://dx.doi.org/10.2174/157488611794479982 |
Print ISSN 1574-8863 |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-3911 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Overlapping the Tryptophan Catabolite (TRYCAT) and Melatoninergic Pathways in Alzheimer's Disease
Current Pharmaceutical Design New Insights in Prolactin Releasing Peptide (Prrp) in the Brain
Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Discontinued) The Contribution of Dopamine to the Implementation of Reward Value During the Control of Action
Central Nervous System Agents in Medicinal Chemistry Transcription, DNA Damage and Beyond: The Roles of Histone Ubiquitination and Deubiquitination
Current Protein & Peptide Science Beyond the Direct Activation of Cannabinoid Receptors: New Strategies to Modulate the Endocannabinoid System in CNS-Related Diseases
Recent Patents on CNS Drug Discovery (Discontinued) Roles of Orexins and Orexin Receptors in Central Regulation of Feeding Behavior and Energy Homeostasis
CNS & Neurological Disorders - Drug Targets Vascular Pharmacotherapy and Dementia
Current Vascular Pharmacology Current Updates on Bone Grafting Biomaterials and Recombinant Human Growth Factors Implanted Biotherapy for Spinal Fusion: A Review of Human Clinical Studies
Current Drug Delivery Prolyl Oligopeptidase Structure and Dynamics
CNS & Neurological Disorders - Drug Targets A Medical Approach to the Monoamine Oxidase Inhibition by Using 7Hbenzo[ e]perimidin-7-one Derivatives
Current Topics in Medicinal Chemistry Autophagy and Mitochondria: Targets in Neurodegenerative Disorders
CNS & Neurological Disorders - Drug Targets The Challenge of microRNA as a Biomarker of Epilepsy
Current Neuropharmacology Amantadine, Apomorphine and Zolpidem in the Treatment of Disorders of Consciousness
Current Pharmaceutical Design Hemodynamic Behavior of Coronary Stents in Straight and Curved Arteries
Current Nanoscience Radiation-Induced Neuroinflammation and Radiation Somnolence Syndrome
CNS & Neurological Disorders - Drug Targets Link of COVID-19 and Neurodegenerative Disorders
CNS & Neurological Disorders - Drug Targets Nanostructures for Drug Delivery to the Brain
Current Medicinal Chemistry Behavioral Tasks Evaluating Schizophrenia-like Symptoms in Animal Models: A Recent Update
Current Neuropharmacology Apoptosis Induction by Ultrasound and Microbubble Mediated Drug Delivery and Gene Therapy
Current Molecular Medicine Combinations Against Combinations: Associations of Anti-HIV 1 Reverse Transcriptase Drugs Challenged by Constellations of Drug Resistance Mutations
Current Drug Metabolism